Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma

Overview of attention for article published in International Journal of Hematology, January 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,653 followers.

Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma. #lymphoma #lymsm https://t.co/GaT4aYaXOL

@DrRaulCordoba @BloodAdvances Nice report! Check our recently reported case https://t.co/jsSSE08wBo 🙂

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.